270 related articles for article (PubMed ID: 28738249)
1. New 1,3,4-oxadiazole/oxime hybrids: Design, synthesis, anti-inflammatory, COX inhibitory activities and ulcerogenic liability.
Abd-Ellah HS; Abdel-Aziz M; Shoman ME; Beshr EAM; Kaoud T; Ahmed AFF
Bioorg Chem; 2017 Oct; 74():15-29. PubMed ID: 28738249
[TBL] [Abstract][Full Text] [Related]
2. Novel 1,3,4-oxadiazole/oxime hybrids: Synthesis, docking studies and investigation of anti-inflammatory, ulcerogenic liability and analgesic activities.
Abd-Ellah HS; Abdel-Aziz M; Shoman ME; Beshr EA; Kaoud TS; Ahmed AF
Bioorg Chem; 2016 Dec; 69():48-63. PubMed ID: 27669120
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization, evaluation and molecular dynamics studies of 5, 6-diphenyl-1,2,4-triazin-3(2H)-one derivatives bearing 5-substituted 1,3,4-oxadiazole as potential anti-inflammatory and analgesic agents.
Banerjee AG; Das N; Shengule SA; Srivastava RS; Shrivastava SK
Eur J Med Chem; 2015 Aug; 101():81-95. PubMed ID: 26117820
[TBL] [Abstract][Full Text] [Related]
4. Novel pyrimidine-pyridine hybrids: Synthesis, cyclooxygenase inhibition, anti-inflammatory activity and ulcerogenic liability.
Abdelgawad MA; Bakr RB; Azouz AA
Bioorg Chem; 2018 Apr; 77():339-348. PubMed ID: 29421710
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, pharmacological screening and in silico studies of new class of Diclofenac analogues as a promising anti-inflammatory agents.
Palkar MB; Singhai AS; Ronad PM; Vishwanathswamy AH; Boreddy TS; Veerapur VP; Shaikh MS; Rane RA; Karpoormath R
Bioorg Med Chem; 2014 May; 22(10):2855-66. PubMed ID: 24751552
[TBL] [Abstract][Full Text] [Related]
6. New indomethacin analogs as selective COX-2 inhibitors: Synthesis, COX-1/2 inhibitory activity, anti-inflammatory, ulcerogenicity, histopathological, and docking studies.
Abdellatif KRA; Abdelall EKA; Elshemy HAH; El-Nahass ES; Abdel-Fattah MM; Abdelgawad YYM
Arch Pharm (Weinheim); 2021 Apr; 354(4):e2000328. PubMed ID: 33314237
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and molecular docking of benzophenone conjugated with oxadiazole sulphur bridge pyrazole pharmacophores as anti inflammatory and analgesic agents.
Zabiulla ; Gulnaz AR; Mohammed YHE; Khanum SA
Bioorg Chem; 2019 Nov; 92():103220. PubMed ID: 31493708
[TBL] [Abstract][Full Text] [Related]
8. Novel 4-methylsulfonylphenyl derivatives as NSAIDS with preferential COX-2 inhibition.
Amin NH; Mohammed AA; Abdellatif KR
Future Med Chem; 2018 Jan; 10(1):53-70. PubMed ID: 29235887
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and analgesic/anti-inflammatory evaluation of novel diarylthiazole and diarylimidazole derivatives towards selective COX-1 inhibitors with better gastric profile.
Abdelazeem AH; El-Saadi MT; Safi El-Din AG; Omar HA; El-Moghazy SM
Bioorg Med Chem; 2017 Jan; 25(2):665-676. PubMed ID: 27916468
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of novel 4-fluorobenzamide-based derivatives as promising anti-inflammatory and analgesic agents with an enhanced gastric tolerability and COX-inhibitory activity.
Halim PA; Georgey HH; George MY; El Kerdawy AM; Said MF
Bioorg Chem; 2021 Oct; 115():105253. PubMed ID: 34390973
[TBL] [Abstract][Full Text] [Related]
11. Novel quinoline incorporating 1,2,4-triazole/oxime hybrids: Synthesis, molecular docking, anti-inflammatory, COX inhibition, ulceroginicity and histopathological investigations.
Mohassab AM; Hassan HA; Abdelhamid D; Abdel-Aziz M; Dalby KN; Kaoud TS
Bioorg Chem; 2017 Dec; 75():242-259. PubMed ID: 29032325
[TBL] [Abstract][Full Text] [Related]
12. New 1,2-diaryl-4-substituted-benzylidene-5-4H-imidazolone derivatives: Design, synthesis and biological evaluation as potential anti-inflammatory and analgesic agents.
Abdellatif KRA; Fadaly WAA
Bioorg Chem; 2017 Jun; 72():123-129. PubMed ID: 28411407
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, Anti-Inflammatory Activity, and COX-1/2 Inhibition Profile of Some Novel Non-Acidic Polysubstituted Pyrazoles and Pyrano[2,3-c]pyrazoles.
Faidallah HM; Rostom SAF
Arch Pharm (Weinheim); 2017 May; 350(5):. PubMed ID: 28370254
[TBL] [Abstract][Full Text] [Related]
14. COX-1/COX-2 inhibition assays and histopathological study of the new designed anti-inflammatory agent with a pyrazolopyrimidine core.
Abdelall EKA; Lamie PF; Ahmed AKM; El-Nahass ES
Bioorg Chem; 2019 May; 86():235-253. PubMed ID: 30716621
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1-phenylpyrazolo[3,4-d]pyrimidine derivatives.
Bakr RB; Azouz AA; Abdellatif KR
J Enzyme Inhib Med Chem; 2016; 31(sup2):6-12. PubMed ID: 27210522
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of new pyrazolone-pyridazine conjugates as anti-inflammatory and analgesic agents.
Khalil NA; Ahmed EM; Mohamed KO; Nissan YM; Zaitone SA
Bioorg Med Chem; 2014 Apr; 22(7):2080-9. PubMed ID: 24631365
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of pyridazinone derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents.
Ahmed EM; Kassab AE; El-Malah AA; Hassan MSA
Eur J Med Chem; 2019 Jun; 171():25-37. PubMed ID: 30904755
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, anti-inflammatory, cytotoxic, and COX-1/2 inhibitory activities of cyclic imides bearing 3-benzenesulfonamide, oxime, and β-phenylalanine scaffolds: a molecular docking study.
Abdel-Aziz AA; El-Azab AS; AlSaif NA; Alanazi MM; El-Gendy MA; Obaidullah AJ; Alkahtani HM; Almehizia AA; Al-Suwaidan IA
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):610-621. PubMed ID: 32013633
[TBL] [Abstract][Full Text] [Related]
19. 1,4-Dihydroquinazolin-3(2H)-yl benzamide derivatives as anti-inflammatory and analgesic agents with an improved gastric profile: Design, synthesis, COX-1/2 inhibitory activity and molecular docking study.
Sakr A; Kothayer H; Ibrahim SM; Baraka MM; Rezq S
Bioorg Chem; 2019 Mar; 84():76-86. PubMed ID: 30481648
[TBL] [Abstract][Full Text] [Related]
20. 1-(4-Methoxyphenyl)-5-(3,4,5-trimethoxyphenyl)-1H-1,2,4-triazole-3-carboxamides: synthesis, molecular modeling, evaluation of their anti-inflammatory activity and ulcerogenicity.
Abdel-Aziz M; Beshr EA; Abdel-Rahman IM; Ozadali K; Tan OU; Aly OM
Eur J Med Chem; 2014 Apr; 77():155-65. PubMed ID: 24631895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
